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Research
Cadmium (Cd) is a well-known occupational 
and environmental hazard with a potent 
nephro  toxic action. Cd concentrates in sev-
eral vital organs, among which liver and kid-
ney are the primary targets that accumulate 
and are affected adversely by this toxic heavy 
metal (Zalups and Ahmad 2002). A body of 
studies provided meaningful insights into the 
Cd uptake and accumulation into renal cells 
(Endo and Shaikh 1993; Zalups and Ahmad 
2002). Once within the cell, Cd reacts with 
thiol groups and may substitute for zinc (Zn) 
in critical metabolic processes, but it can also 
cause DNA single-strand breaks, lipid per-
oxidation, and generation of oxidatively dam-
aged proteins (Bertin and Averbeck 2006). 
Enterally absorbed Cd is taken up by the liver, 
where a significant amount of its ionized form 
(Cd2+) is bound to metallo  thioneins (MTs), 
leading to hepato  cellular necrosis and/or apop-
tosis, with the consequent release of Cd–MT 
complexes into the bloodstream. Some of 
these complexes are delivered to the kidneys, 
where they are filtered by the glomeruli and 
reabsorbed by the proximal tubules (Zalups 
and Ahmad 2002). Kidneys can accumulate 
up to 50% of the total body burden of Cd in 
subjects occupationally and environmentally 
exposed (Järup 2002), causing a decrease in 
tubular reabsorption and leading to proximal 
tubulopathies characterizing renal Fanconi’s 
syndrome (Hamada et al. 1997; Prozialeck 
et al. 1993). Although Cd-induced nephro-
toxicity is widely studied, the molecular mecha-
nisms underlying the damage and subsequent 
regeneration of the renal tubular epithelium 
remain elusive.
An extensive endocytic apparatus, located 
in the apical membrane of proximal tubule 
cells, plays a key role in the reabsorption and 
degradation of glomerular-filtered albumin and 
low-molecular-weight proteins (Marshansky 
et al. 2002) and in the recycling of many func-
tionally important apical membrane transport-
ers (Brown and Stow 1996). Human kidney is 
able to reabsorb 95% of all filtered albumin via 
receptor-mediated endocytosis within proximal 
tubules (Nielsen 1993). Albumin endocytosis 
requires a macro  molecular protein complex 
formed by the megalin/cubilin scavenger recep-
tor Na+-H+ exchanger isoform 3 (NHE3), 
vacuo  lar proton-ATPase (v-H+-ATPase), and 
chloride channel 5 (ClC5). The megalin/cubilin   
receptor binds albumin, which is subsequently 
internalized by clathrin-coated pits into 
endosomes that are acidified by NHE3 and 
v-H+-ATPase. The anion shunt is provided 
by ClC5 (Christensen and Birn 2001; Hryciw 
et al. 2006).
Previous reports have shown in vivo 
that Cd alters the expression of NHE3 and 
v-H+-ATPase (Ahn et al. 2005; Herak-
Kramberger et al. 1998). To take this one step 
further, we examined whether Cd exposure 
affects the expression of the two other proteins 
involved in renal albumin endo  cytosis: mega-
lin and ClC5. In proximal tubule cells, mega-
lin, a 600-kDa trans  membrane glycoprotein, 
inter  acts synergistically with cubulin as scav-
enger for the luminal uptake of a large number 
of proteins, including albumin (Verroust et al. 
2002). Moreover, ClC5 is mainly expressed 
in the early endosomes of the renal proximal 
tubule and intercalated cells of the cortical 
collecting duct (Jentsch et al. 2002; Piwon 
et al. 2000). Heterologous expression of ClC5 
in Xenopus laevis oocytes or HEK 293 cells 
(Devuyst et al. 1999) showed that it mediates 
plasma membrane currents (Schriever et al. 
1999). Because ClC5 acts as a chloride/proton 
exchanger when activated by positive voltages 
(Picollo and Pusch 2005), it is believed to 
play a critical role in the endosomal acidifi-
cation as an antiporter by coupling chloride 
ion (Cl–) gradients to vesicular pH gradients 
(Picollo and Pusch 2005). Knockout mice 
lacking functional megalin or ClC5 have 
both albuminuria and low-molecular-weight 
proteinuria, hallmarks of renal Fanconi’s syn-
drome (Christensen et al. 2003; Leheste et al. 
1999; Piwon et al. 2000; Wang et al. 2000). 
This led us to investigate effects of Cd on the 
expression, sub  cellular distribution, and pos-
sible functional implications of both megalin 
and ClC5 in the Cd-induced dysregulation of 
renal proximal tubule albumin reabsorption.
Materials and Methods
Cell culture. We obtained a pig renal proximal 
tubule cell line (LLC-PK1) from American 
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Ba c k g r o u n d: Cadmium (Cd) is a potent nephrotoxicant that impairs the reabsorptive and secretory 
functions of the renal proximal tubule, leading to albuminuria.
Objectives: To gain insights into the mechanisms of Cd-induced albuminuria, we investigated 
effects of Cd on the expression of megalin and chloride channel 5 (ClC5), two key players in albumin- 
receptor–mediated endocytosis.
Methods: We used quantitative polymerase chain reaction, Western blotting, the albumin endo-
cytosis assay, and confocal microscopy to evaluate effects of Cd on the expression and regulation of 
megalin and ClC5 in cultured LLC-PK1 cells, a pig proximal tubular cell model.
Results: Ten micromolar cadmium chloride (CdCl2) caused a significant time- and dose-dependent 
decrease in both mRNA and protein levels of megalin and ClC5, whereas no changes resulted from 
exposure to other divalent metals (zinc chloride, manganese chloride, magnesium chloride, and nickel 
chloride). After inhibiting protein synthesis using cycloheximide (CHX), we found that levels of both 
megalin and ClC5 were lower in Cd-challenged cells than in cells treated with Cd or CHX only, 
which is consistent with reduced translation and/or post    translational down-regulation. Moreover, 
Cd-induced degradation of megalin and ClC5 was abolished by the lysosomal pathway inhibitor 
bafilomycin A-1 but not by the proteasome system blocker MG-132, suggesting that the enhanced 
proteo  lysis was occurring via lysosomes. Using confocal microscopy, we observed a remarkable 
reduction of fluoro  isothiocyanate (FITC)-labeled albumin uptake after Cd exposure. 
Conclusions: We found that Cd reduced the transcriptional expression of megalin and ClC5 
and, at the same time, increased the degradation of megalin and ClC5 proteins via the lysosomal 
pathway in an in vitro model of renal proximal tubular cells. Overall, these results provide valuable 
insights into the molecular mechanisms by which Cd impairs luminal protein reabsorption by renal 
proximal tubules.
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Type Culture Collection (ATCC, Rockville, 
MD, USA). LLC-PK1 cells were grown in 
low-glucose Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% 
fetal bovine serum, 50 U/mL penicillin, and 
10 ng/mL streptomycin (Invitrogen, Carlsbad, 
CA, USA) in a humidified atmosphere of 5% 
CO2/95% air at 37°C. Cells were grown and 
subcultured every week on Transwell inserts 
(pore size, 0.4 μm; Fisher, Newark, DE, 
USA). Cell mono  layers were used 1 day post-
confluence, typically 7 days after seeding.
Treatment with Cd and divalent metals 
manganese (Mn), magnesium (Mg), zinc (Zn), 
and nickel (Ni). Cd, Zn, Mn, Mg, and Ni 
chloride salt forms were purchased from Sigma 
Chemicals (St. Louis, MO, USA). Confluent 
cell mono  layers were washed twice with phos-
phate-buffered saline (PBS) and incubated 
with serum-free medium containing the suit-
able concentration of all divalent metals for 
9 hr at 37°C. Divalent metals were added both 
to the lower (10 μM) and to the upper (1 μM) 
compartment of the Transwell clusters cor-
responding to the baso  lateral and the apical 
membrane side of the cells, respectively. In 
the time course experiments, cells were treated 
with 10 μM CdCl2 for 3–24 hr. After the 
exposure, Cd-treated cells were washed three 
times with PBS to remove the residual metals. 
Untreated cells were incubated only with the 
serum-free DMEM and treated as the cells 
exposed to the metals.
CHX, bafilomycin A1, and MG-132 treat-
ments. Cycloheximide (CHX), bafilo  mycin A1 
(Sigma), and carbobenzoxy-l-leucyl-l-leucyl-l-
leucinal (MG-132) (Calbiochem, San Diego, 
CA, USA) were dissolved in dimethyl sulfoxide 
(DMSO). LLC-PK1 cells were incubated with 
serum-free medium containing each chemical 
or DMSO alone at the same concentration 
used in treated cells (0.1% or 0.05%).
Cytotoxicity studies. Cd-induced cytotoxic-
ity and cellular damage were both evaluated 
by trypan blue exclusion, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium-bromide 
(MTT), and lactate dehydrogenase leakage 
(LDH) assays. LLC-PK1 cells were plated at 
1 × 106 cells/dish and cultured for 2–3 days 
in a serum-free medium. The trypan blue 
exclusion test was carried out according to 
the manu  facturer’s (Sigma) instructions. For 
the MTT assay, both control and Cd-treated 
cells were incubated for 4 hr with 0.8 mg/mL   
MTT dissolved in serum-free medium. 
Washings with PBS were followed by adding 
DMSO and shaking for 10 min to achieve the 
complete dissolution. Aliquots of the resulting 
solutions were transferred into 96-well plates, 
and absorbance was recorded spectrophotomet-
rically at 570 nm. The LDH assay, a colorimet-
ric test to evaluate cell integrity, was performed 
using a cytotoxicity detection kit from Roche 
Diagnostics GmbH (Mannheim, Germany).
Quantitative real-time reverse-transcriptase 
polymerase chain reaction (qRT-PCR). We 
extracted total RNA from LLC-PK1 cells 
using the RNeasy Mini Kit (Qiagen, Valencia, 
CA, USA). One microgram of total RNA 
from each sample was reverse transcribed to 
cDNA. Equal amounts of the resulting cDNA 
were used as templates for the subsequent 
quantitative real-time RT-PCR reactions that 
were set up using the following final concen-
trations: 200 nM each of forward and reverse 
primers [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0901874)], 1× SYBR 
Green PCR Master Mix (Applied Biosystems, 
Foster City, CA, USA), and 1.0 μL cDNA. 
Quantitative real-time RT-PCR was carried 
out using the following cycling conditions: ini-
tial incubation (50°C, 2 min), Taq activation 
(95°C, 3 min), and 40 cycles of denaturation 
(95°C, 1 min), annealing (60°C, 1 min), and 
extension (72°C, 1 min). After 40 PCR cycles, 
the temperature was increased from 72°C to 
95°C to construct a melting curve. Data were 
normalized against β-actin.
Western blotting. After the treatments, 
cells were washed twice with PBS and har-
vested with lysis buffer [60 mM HEPES, 
(pH 7.5), 150 mM NaCl, 3 mM KCl, 5 mM 
EDTA, 5 mM EGTA, 1% Triton X-100, and 
complete protease inhibitor cocktail (all from 
Roche Diagnostics, Indianapolis, IN, USA)]. 
Lysates were insulin-syringe homogenized and 
centrifuged at 6,000 × g for 10 min at 4°C. 
The resulting super  natant was retained, and 
the protein concentration was determined 
using the BCA Protein Assay Kit (Pierce, 
Rockford, IL, USA). Equal protein amounts 
(40 μg) were incubated in Laemmli buffer 
for 30 min at 37°C and electrophoresed in 
7.5% SDS/PAGE gels (Bio-Rad, Hercules, 
CA, USA). Resolved proteins were then trans-
ferred onto a polyvinyl difluoride membrane 
and blocked in 5% (wt/vol) low-fat milk in 
blocking buffer (20 mM Tris-HCl, 0.15 mM 
NaCl, 1% Triton X-100, pH 7.5) for 1 hr 
at room temperature. Blots were incubated 
overnight with sheep anti-megalin (kindly 
provided by O. Devuyst, Louvain, Belgium), 
goat polyclonal anti-ClC5 (ClC5-D17), 
or anti-actin (I-19) antibodies (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). 
Proteins were detected with SuperSignal West 
Dura Extended Duration Substrate (Pierce). 
Acquired images were analyzed by Image J 
software (Rasband 2009).
Albumin endocytosis assay and immuno-
fluorescent staining. The albumin endocytosis 
assay was performed as previously described 
(Wang et al. 2005). Briefly, LLC-PK1 cells 
were grown on Transwell inserts in supple-
mented DMEM for 7 days to ensure that 
the cells were polarized before the experi-
ments. After Cd exposure for 9 hr, cells were 
washed twice with PBS supplemented with 
1.8 mM CaCl2 and 1.0 mM MgCl2 (PBS2+) 
and exposed from their apical surfaces to pre-
warmed fluoroisothiocyanate (FITC)-labeled 
albumin (0.5 mg/mL) at 37°C for 15 min. 
Cells held at 4°C to abolish the endocytic 
process were used as negative controls. Before 
fixation, cells were put on ice and washed 
with ice-cold PBS2+ eight times to block albu-
min endocytosis. Then, they were fixed with 
4% paraformaldehyde at room tempera  ture 
for 15 min, permeabilized with 0.1% Triton 
X-100 for 1–2 min, and blocked with 0.1% 
gelatin in PBS2+ for 30 min. Cell mono-
layers were incubated with sheep anti-megalin 
or rabbit anti-ClC5 antibodies (Millipore, 
Temecula, CA, USA) in blocking solution 
for 1 hr, washed with PBS2+ three times, and 
incubated with the appropriate secondary 
anti  body conjugated to Cy3 fluorescent dye 
(Jackson Immunoresearch, West Grove, PA, 
USA). In some experiments, cells were fixed 
and immuno  stained with fluorescent wheat 
germ agglutinin (WGA; Invitrogen) for 1 hr. 
After staining, the Transwells were washed 
thoroughly with PBS and mounted with an 
anti  quenching medium. Finally, slides were 
sealed and viewed with a Zeiss Axiovert 
200 fluorescence microscope equipped with 
510-Meta confocal module (Carl Zeiss, 
Oberkocken, Germany) and fitted with a 
63× oil-immersion objective lens. Fluorescent 
images were acquired and analyzed by meas-
uring the average intensity per cell from mul-
tiple images after background subtraction 
using IPLAB software (BD Biosciences, San 
Jose, CA, USA).
Statistical analysis. We used Student’s 
t-test to determine the statistical significance. 
Results were expressed as mean ± SE and cal-
culated based on three to five independent 
experiments. A p-value < 0.05 was considered 
to be statistically significant.
Results
Cd down-regulates gene expression of mega-
lin and ClC5 in proximal tubule cells. We 
performed quantitative real-time RT-PCR 
to evaluate time course and dose effects of 
CdCl2 treatment on megalin and ClC5 
mRNA expression in proxi  mal tubule cells. 
In LLC-PK1 cells incubated with 10 μM 
CdCl2, the mRNA levels of both megalin 
and ClC5 decreased significantly until 9 hr of 
treatment (–90.3 ± 3.3% and –55.4 ± 7.1%, 
respectively) and remained consistently low 
at 24 hr (Figure 1A). When cells were treated 
with 2–50 μM CdCl2 for 9 hr, both mega-
lin and ClC5 mRNA levels were reduced in 
a dose-dependent manner (Figure 1B,C). 
Interestingly, megalin expression was much 
more sensitive to Cd than was ClC5 expres-
sion. Megalin and ClC5 mRNA expressions 
were normalized against β-actin expression, 
which was unaffected by CdCl2 exposure Megalin and ClC5 in Cd-induced albuminuria
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(Figure 1A–C). At 9 hr of Cd treatment, cell 
viability (assayed by trypan blue exclusion) 
was unchanged at concentrations ≤ 10 μM 
but decreased by 38% and 45% at 25 and 
50 μM CdCl2, respectively (data not shown). 
We confirmed absence of intoxication with 
exposures up to 25 μM CdCl2 using MTT 
and LDH assays [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0901874)]. 
Metabolic activity and cellular integrity seen in 
our experimental conditions were thoroughly 
in line with previous studies that used con-
focal microscopy, flow cytometry, and LDH 
cytotoxicity assays to show that Cd induces 
apoptosis in LLC-PK1 cells only at relatively 
high Cd concentrations (50–100 μM) and 
after a prolonged exposure (24 hr) (Alvarez-
Barrientos et al. 2001; Gennari et al. 2003). 
Because CdCl2 in aqueous solution is known 
to cause acute nephro  toxicity in cultured 
proxi  mal tubule cells (Barbier et al. 2005; 
Liu et al. 1994), we carried out a Cd chal-
lenge using in vitro experiments in which 
we exposed cultured LLC-PK1 cells to low 
micro  molar concentrations of Cd2+. All of 
the experiments except the dose responses 
(Figure 1B,C) used 10 μM CdCl2.
CdCl2 specifically reduces megalin and 
ClC5 transcript levels. To determine whether 
the decrease in megalin and ClC5 at the gene 
level after Cd treatment was specific to this 
metal, we incubated LLC-PK1 cells for 9 hr 
with 10 μM of other divalent metals such 
as Zn2+, Mn2+, Mg2+, and Ni2+. Cell viabil-
ity, meas  ured by trypan blue exclusion assay, 
was 92.8 ± 3.7% for CdCl2, 97.5 ± 2.4% for 
ZnCl2, 96.3 ± 1.9% for MnCl2, 98.8 ± 0.4% 
for MgCl2, and 93.3 ± 6.6% for NiCl2. 
Quantitative real-time RT-PCR results 
showed that, among the metals examined, 
only Cd treatment significantly reduced the 
mRNA levels of megalin and ClC5 in LLC-
PK1 cells (Figure 1D,E), indicating that the 
Cd-induced down-regulation of megalin and 
ClC5 gene expression was not a general effect 
exerted by divalent metals. However, the most 
relevant control was Zn, which, like Cd, is 
another group IIB transition metal. To evalu-
ate whether CdCl2 caused a general down-
regulation of gene expression in proximal 
tubule cells, we compared the transcript levels 
of megalin and ClC5 with those of 78-kDa 
glucose-regulated protein (Grp78), a well-
known Cd-inducible target (Liu et al. 2006), 
and aquaporin-1 (Aqp1), a plasma mem-
brane protein unaffected by CdCl2 treatment 
(Sabolic et al. 2002). As shown in Figure 1F, 
CdCl2 exposure resulted in a time-dependent 
increase in Grp78 mRNA expression, whereas 
it had no effect on Aqp1 mRNA levels. These 
results suggested that the inhibitory effects of 
Cd on megalin and ClC5 mRNA in LLC-PK1 
cells were specific to CdCl2 and could not be 
attributed to an overall down-regulation of 
gene expression resulting from cytotoxicity.
Time course of CdCl2-induced down- 
regulation of megalin and ClC5 protein 
expression. We performed immuno  blotting 
experiments to study time- and dose-depen-
dent effects of Cd exposure on both megalin 
and ClC5 protein levels. Consistent with the 
results of quantitative real-time RT-PCR, in 
LLC-PK1 cells treated with 10 μM CdCl2, 
megalin and ClC5 protein expression began to 
decrease significantly after 9 hr (–41.2 ± 7.2% 
and –27.7 ± 10.2%, respectively), with a 
peak reduction at 24 hr (–80.2 ± 1.4% and 
–61.6 ± 3.1%, respectively) (Figure 2A–C). 
In agreement with the mRNA studies, mega-
lin appeared to be more sensitive to Cd than 
was ClC5. The protein levels of megalin and 
ClC5 were normalized against β-actin, which 
was unaltered after 2–24 hr of CdCl2 expo-
sure (Figure 2A–C). Experiments to evaluate 
megalin and ClC5 protein expressions after 
exposure to increasing doses of CdCl2 for 
9 hr also supported dose-dependent effects, 
with stronger effects on megalin than on 
ClC5 [see Supplemental Material, Figure 2 
(doi:10.1289/ehp.0901874)].
Figure 1. Cd reduces the gene expression of megalin and ClC5 in LLC-PK1 cells compared with controls. (A) Time course of megalin and ClC5 gene expression in 
LLC-PK1 cells incubated with 10 μM CdCl2 for 3–24 hr, showing large decreases in ClC5 and megalin mRNA levels in response to Cd. (B and C) Dose-dependent 
effects of Cd on megalin (B) and ClC5 (C) mRNA levels upon treatment of proximal tubule cells with 0, 2, 5, 10, 25, or 50 μM CdCl2 for 9 hr. (D and E) Quantitative real-
time RT-PCR histograms showing megalin (D) and ClC5 (E) mRNA levels in LLC-PK1 cells incubated with 10 μM of each divalent metal compound for 9 hr. Unlike the 
Cd challenge, cells exposed to various divalent metals showed no effects on megalin and ClC5 mRNA levels; the purity of all divalent metals was ≤ 5 ppm of heavy 
metals contamination. (F) Quantitative real-time RT-PCR performed on LLC-PK1 cells treated with 10 μM CdCl2 for 3–24 hr; using specific primers for Grp78, Aqp1, 
megalin, ClC5, and β-actin indicates that the inhibitory effects of Cd are specific to megalin and ClC5 gene expression. All values were normalized against β-actin 
expression; control values (time zero for A and F, and absence of CdCl2 for B–E) were set to 100%. Values are mean ± SE of four experiments. 
*p < 0.05 compared with untreated controls.
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Cd-induced down-regulation of mega-
lin and ClC5 proteins is due to an increase 
of their lysosomal degradation. To address 
the possible molecular mechanism by which 
Cd dys  regulated megalin and ClC5 both at 
the protein and at the gene levels, we incu-
bated LLC-PK1 cells with 10 μg/mL of 
CHX, a protein synthesis inhibitor, in the 
presence or absence of 10 μM CdCl2 for 
9 hr. CHX treatment significantly reduced 
the expression of both proteins in CdCl2-
challenged cells (–74.4 ± 10.4% for megalin, 
and –50.3 ± 11.2% for ClC5) compared with 
untreated cells and cells treated with CdCl2 
or CHX only (Figure 3A–C). Results showing 
Figure 2. Megalin and ClC5 protein levels are remarkably decreased in Cd-treated proximal tubule cells compared with controls. (A) Representative Western blots of 
cell lysates (prepared from LLC-PK1 cells exposed to 10 μM CdCl2 for 3–24 hr) incubated with megalin, ClC5, and actin antibodies; Cd exposure significantly reduced 
megalin and ClC5 protein levels starting at 9 hr, with a peak reduction at 24 hr. (B and C) Densitometric analyses of megalin (B) and ClC5 (C) protein from Western 
blots shown in A. All values were normalized against β-actin expression; the control value (time zero) was set to 100%. Values are mean ± SE of four experiments. 
*p < 0.05 compared with untreated controls.
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Figure 3. Megalin and ClC5 are reduced in presence of Cd and CHX, a protein synthesis inhibitor, compared with controls. (A) Representative Western blots of cell 
lysates [prepared from LLC-PK1 cells incubated for 9 hr with 10 μM CdCl2, 10 μg/mL CHX, 10 μg/mL CHX plus 10 μM CdCl2 or serum-free medium containing 0.1% 
DMSO (the same concentration used in treated cells)] incubated with megalin, ClC5, and actin anti  bodies. Cd treatment plus CHX significantly decreased levels 
of both proteins, especially megalin, relative to levels in cells treated with Cd or CHX only. (B and C) Densitometric analyses of megalin (B) and ClC5 (C) protein 
from Western blots shown in A. Values were normalized against β-actin expression, and the control value (without CdCl2 and/or CHX) was set to 100%. Values are 
mean ± SE of three experiments. 
*p < 0.05 compared with untreated controls. #p < 0.05 compared with cells treated with Cd only.
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Figure 4. Megalin and ClC5 undergo enhanced degradation via the lysosomal pathway. (A) Representative Western blots of cell lysates from LLC-PK1 cells 
incubated for 9 hr with 10 μM CdCl2, 10 μM MG-132, or 10 μM MG-132 plus 10 μM CdCl2. (B and C) Densitometric analyses of megalin (B) and ClC5 (C) protein from 
Western blots shown in A. (D) Western blots of cell lysates from LLC-PK1 cells exposed for 9 hr to 10 μM CdCl2, 1 μM bafilomycin A-1 (Bafilo), or 1 μM Bafilo plus 
10 μM CdCl2. (E and F) Densitometric analyses of megalin (E) and ClC5 (F) protein from Western blots shown in D. Untreated controls were incubated with serum-
free medium containing 0.1% DMSO, the same concentration used in treated cells. For B, C, D, and F, all values were normalized against β-actin expression, and 
the control values were set to 100%. Values are mean ± SE of three experiments.
*p < 0.05 compared with untreated controls. #p < 0.05 compared with cells treated with Cd only.
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reduced abundance of megalin and ClC5 pro-
tein upon treatment with CdCl2 and CHX 
are consistent with reduced protein expression 
due to effects on transcription but might also 
reflect a Cd-induced increase in proteo  lytic 
degradation of both proteins via lysosomal or 
proteasomal pathways. To assess whether the 
reduction in both megalin and ClC5 protein 
expression was due to an effect of Cd on pro-
tein degradation dependent on the ubiquitin/
proteasome or the lysosomal pathways, we 
treated LLC-PK1 cells with 10 μM MG-132, 
a proteasome inhibitor (Rock et al. 1994), 
or 1 μM bafilomycin A1, a lyso  somal proton 
pump inhibitor (Yoshimori et al. 1991), in the 
presence or absence of 10 μM CdCl2 for 9 hr. 
Megalin and ClC5 proteins were still signifi-
cantly reduced in CdCl2-treated cells exposed 
to MG-132 (Figure 4A–C). In contrast, 
when cells were treated with bafilo  mycin A1,   
the effects of Cd on megalin and ClC5 pro-
tein levels were completely abolished, with lev-
els remaining unchanged (Figure 4D–F). We 
observed no significant change in protein abun-
dance in LLC-PK1 cells treated with bafilo-
mycin only, consistent with an effect of Cd on 
lysosomal protein degradation. Overall, these 
results indicated that, in addition to reducing 
mRNA levels (Figure 1), Cd promoted the 
degradation of megalin and ClC5 proteins via 
lysosomes rather than via proteasomes.
Effect of CdCl2 on albumin endocytosis. 
To investigate the effect of CdCl2 on albu-
min endocytosis, we preincubated LLC-PK1 
cell monolayers with 10 μM CdCl2 for 9 hr 
and then treated them with 0.5 mg/mL 
FITC-labeled albumin for 30 min at 37°C. 
Consistent with previous reports (Choi et al. 
1999; Lebeau et al. 2001), confocal micros-
copy showed that FITC-albumin uptake 
was remarkably reduced in Cd-treated cells 
(Figure 5C,D) compared with controls 
(Figure 5A,B). By quantitative analysis, the 
FITC-albumin uptake of Cd-treated mono-
layers, measured as average fluorescence 
intensity per cell, was decreased by 68 ± 10% 
compared with untreated control cells 
(Figure 5E). In line with the observed dose 
dependence of the Cd effect, we observed no 
changes in FITC-albumin uptake with lower 
doses (2–5 μM) of Cd2+ (data not shown). No 
FITC-albumin uptake was seen in LLC-PK1 
cells exposed to FITC-albumin at 4°C (nega-
tive controls). In contrast with the untreated 
control cells, which showed an accumulation 
of FITC-albumin in the intra  cellular compart-
ment (Figure 5A, green), in Cd-challenged 
cells FITC-albumin colocalized (yellow; 
Figure 5B) with rhodamine-labeled WGA 
(red), a well-known apical membrane marker 
(Sambuy et al. 1988). These observations 
suggest that CdCl2 exposure blocked apical 
receptor-mediated FITC-albumin endocyto-
sis and thereby prevented internalization of 
albumin into the cytoplasmic compartment 
of the proximal tubule cells.
Confocal microscopy of labeled FITC-
albumin and megalin or ClC5 in CdCl2-
treated cells indicated a simultaneous decrease 
in FITC-albumin and both proteins [see 
Supplemental Material, Figure 3 (doi:10.1289/
ehp.0901874)].
Discussion
Kidney proximal tubule cells are among the 
major targets of Cd-induced renal injury (Van 
Vleet and Schnellmann 2003). However, the 
sub  cellular mechanism underlying Cd nephro-
toxicity remains poorly understood. We car-
ried out this study based on the working 
hypothesis that the enhanced albuminuria that 
  charac  terizes Cd-treated proximal tubule cells 
is due to impaired endo  cytosis caused by dys-
regulatory effects exerted by Cd2+ on megalin 
and ClC5, two proteins that play key roles 
in albumin-receptor–mediated endocytosis. 
In vivo, Cd-MT treatment exerted acute effects 
on both the abundance and sub  cellular distri-
bution of megalin (Sabolic et al. 2002). In our 
study we took these results a step further to 
provide a deeper understanding of the mecha-
nisms and molecu  lar pathways involved in Cd 
nephro  toxicity using a well-established in vitro 
renal cell model. Our results show down-
  regulation of both megalin and ClC5 at both 
the protein and gene levels in a time- and dose-
dependent manner. We observed no change 
in the transcriptional expression of megalin 
Figure 5. FITC-albumin endocytosis is impaired in Cd-challenged proximal tubule cells. (A and B) FITC-
albumin endocytosis assay using LLC-PK1 cells incubated in control conditions (without CdCl2; CTRL) and 
exposed for 15 min to 0.5 mg/mL FITC-labeled albumin. Albumin internalization is shown by the numerous 
fluorescent vesicles (green) located in the subapical (arrows) and intracellular (arrowheads) compart-
ments. (C and D) Confocal imaging of FITC-albumin endocytosis by LLC-PK1 cells after 9 hr treatment with 
10 μM CdCl2 and 15 min exposure to 0.5 mg/mL FITC-labeled albumin; FITC-albumin uptake was remarkably 
reduced in CdCl2-treated cells compared with the control cells. Insets: colocalization (arrowhead; yellow) 
between rhodamine-labeled WGA (red), an apical membrane marker, and FITC-albumin (green) in CdCl2-
exposed cells (B) compared with control cells (A). Nuclei are labeled with 4´,6-diamidino-2-phenylindole 
(DAPI; blue). In A and C, bars = 20 μm; for B and D, magnification, 63×. For insets in A and B, magnification, 
100×. (E) Quantitative analysis of FITC-albumin endocytosis, measured as average fluorescence intensity 
per cell, in control and Cd-challenged cells. Values are mean ± SE of five experiments.
*p < 0.05 compared with untreated controls. 
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and ClC5 in LLC-PK1 cells treated with other 
divalent metals (Zn2+, Mn2+, Mg2+, and Ni2+), 
indicating that this effect was specific to Cd2+. 
In addition, effects of Cd2+ on megalin and 
ClC5 were not the consequence of mere cellular 
damage. After Cd exposure, altered expression 
of megalin and ClC5 may reflect the distinct 
accumulation and biochemical properties of 
this toxic metal. Because Cd is not a redox-
active metal, it is reasonable to assume that it is 
not directly involved in Fenton-type reactions 
and does not generate free radicals by itself 
(Stohs and Bagchi 1995). However, Cd can 
induce oxidative stress indirectly by reducing 
cellular anti  oxidants and causing the release of 
reactive oxygen species (ROS) by mitochondria 
(Waisberg et al. 2003). Hence, based on previ-
ous reports (Thévenod and Friedmann 1999), 
we hypothesize that Cd-induced reduction of 
megalin and ClC5 mRNA levels is the conse-
quence of an indirect effect of this heavy metal 
on DNA transcription involving ROS produc-
tion and oxidative stress. Our observation that 
cells treated with Cd and CHX (to inhibit pro-
tein synthesis) had reduced protein abundance 
relative to cells treated with Cd or CHX alone 
may be partly explained by reduced transcrip-
tion, but might also reflect increased degrada-
tion of megalin and ClC5 in Cd-challenged 
proximal tubule cells. The fact that protein 
levels in cells treated with Cd and bafilomy-
cin A-1, a lysosomal pathway inhibitor, were 
comparable to protein levels in untreated cells 
suggests that Cd2+ targets megalin and ClC5 
for enhanced proteo  lysis through lysosomes. 
In contrast, protein levels were comparable in 
Cd-treated cells with or without MG-132, a 
proteasome system blocker. In kidney proximal 
tubule cells, Cd-mediated oxidative stress leads 
to degradation of Na+/K+-ATPase through the 
proteasomal and endo-/lysosomal pathways 
(Thévenod and Friedmann 1999). Similarly, 
it is reasonable to speculate that Cd acts on 
megalin and ClC5 expression simultaneously 
and at two distinct levels: by reducing tran-
scription of megalin and ClC5 mRNA, and 
by increasing megalin and ClC5 degradation 
through the lysosomal pathway. It is there-
fore conceivable that the changes in mRNA 
levels observed in response to Cd2+ did not 
necessarily determine the level of megalin and 
ClC5 protein expression. The remarkable inhi-
bition of albumin uptake and internalization, 
which was associated with a significant reduc-
tion in the expression of megalin (at the cell 
margins and in intra  cellular vesicles) and ClC5 
(in intra  cellular vesicles) in Cd-challenged 
cells, was consistent with the recent work by 
Lebeau et al. (2001), who reported that expos-
ing opossum kidney cell mono  layers to Cd 
for 24 hr inhibited the endocytic mechanism 
of protein reabsorption and that such inhibi-
tion was due to a Cd-induced reduction in the 
number of recycling receptors that internalize 
low-molecular-weight proteins. However, the 
colocalization of WGA and albumin that we 
observed indicated that albumin was bound 
to its plasma membrane receptor in LLC-PK1 
cells even after Cd treatment. This suggests 
either that megalin is not primarily impor-
tant for binding albumin, so that other recep-
tors can substitute for megalin, or that reduced 
megalin expression is not sufficient to abolish 
albumin binding completely. The same effect 
of Cd on megalin and ClC5 expression was 
previously observed for other proteins involved 
in albumin-receptor–mediated endocytosis, 
including NHE3 and v-H+-ATPase (Ahn et al. 
2005; Herak-Kramberger et al. 1998).
Overall, our data suggest that the nephro-
toxicant action of Cd causes a global down-
regulation of all proteins involved in the 
macromolecular complex required for albu-
min-receptor–mediated endocytosis, with con-
sequent albuminuria. This may be of clinical 
and diagnostic significance because albuminu-
ria per se is well recognized as a cause of tubu-
lar damage and as a biomarker of renal and 
cardio  vascular diseases. Therefore, improv-
ing knowledge of the molecular mecha  nisms 
of Cd toxicity may reveal information of 
therapeutic relevance for renal diseases with   
associated albuminuria.
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